Tonix Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tonix Pharmaceuticals (TNXP).

Price Target Range — 4 Quarters

Analyst Consensus — 5 Analysts

1S.Buy

4Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$39Upside to Avg. PT+343.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 25, 2026	Raymond James	Tiago Fauth	Initiate	Strong Buy	$26
May 4, 2026	TD Cowen	Stacy Ku	Initiate	Buy	$22
Mar 20, 2025	Noble Capital Markets	Robert LeBoyer	Maintained	Outperform	$70
Jul 22, 2024	Alliance Global Partners	James Molloy	PT Raise	Buy	$6→$11
Feb 28, 2024	Dawson James	Jason Kolbert	Initiate	Buy	$3

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Watching Tonix Pharmaceuticals; Zacks Small-Cap Research Gives Stock $64 Price Valuation

Benzinga Newsdesk

This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

Top Wall Street analysts changed outlook on top names. See all changes incl. upgrades, downgrades & initiations on analyst ratings page.

Avi Kapoor

This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday

Wall Street analysts change outlook on top names, with downgrades and initiations. See analyst ratings page for complete view.

Avi Kapoor

This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts changed outlook on top names, including Intel and Arrow Financial. See ratings page. TNXP stock may be worth considering, analysts say.

Avi Kapoor

PRO
Raymond James Initiates Coverage On Tonix Pharmaceuticals with Strong Buy Rating, Announces Price Target of $26

Raymond James analyst Tiago Fauth initiates coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) with a Strong Buy rating and announces Price Target of $26.

Benzinga Newsdesk

PRO
TD Cowen Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $22

TD Cowen analyst Stacy Ku initiates coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy rating and announces Price Target of $22.

Benzinga Newsdesk

Tonix Pharmaceuticals Holding Corp

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Tonix Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Watching Tonix Pharmaceuticals; Zacks Small-Cap Research Gives Stock $64 Price Valuation

This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday

This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
Raymond James Initiates Coverage On Tonix Pharmaceuticals with Strong Buy Rating, Announces Price Target of $26

PRO
TD Cowen Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $22

People Also Watch

People Also Watch

Tonix Pharmaceuticals Holding Corp

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Tonix Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWatching Tonix Pharmaceuticals; Zacks Small-Cap Research Gives Stock $64 Price Valuation

This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday

This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRORaymond James Initiates Coverage On Tonix Pharmaceuticals with Strong Buy Rating, Announces Price Target of $26

PROTD Cowen Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $22

People Also Watch

People Also Watch

PRO
Watching Tonix Pharmaceuticals; Zacks Small-Cap Research Gives Stock $64 Price Valuation

PRO
Raymond James Initiates Coverage On Tonix Pharmaceuticals with Strong Buy Rating, Announces Price Target of $26

PRO
TD Cowen Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $22